Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec;11(12):1604-1608.
doi: 10.1002/mdc3.14193. Epub 2024 Oct 14.

Clinicodemographic and Genetic Modifier Correlation in an X-Linked Dystonia-Parkinsonism Cohort from Mindanao

Affiliations

Clinicodemographic and Genetic Modifier Correlation in an X-Linked Dystonia-Parkinsonism Cohort from Mindanao

Maria Leila M Doquenia et al. Mov Disord Clin Pract. 2024 Dec.

Abstract

Background: X-linked dystonia-parkinsonism (XDP), a neurodegenerative movement disorder endemic to the Philippines, is primarily investigated in patients from Panay Island and the Greater Manila area. However, individuals residing in geographically distant regions may exhibit different clinical or genetic characteristics compared to those documented in earlier reports.

Objective: The aim was to investigate the relationship of XDP clinical features in a Mindanao cohort with modifiers of age at onset (AAO) variability and utilization of a previously reported AAO model.

Methods: We investigated clinical and genetic features in 27 XDP patients from southern Mindanao. In all patients, we genotyped the 4 polymorphisms linked to AAO.

Results: The XDP-relevant hexanucleotide repeat number significantly correlated with AAO in the 27 patients and explained about 68% of AAO variability. There is no statistical difference between the predicted and actual AAO.

Conclusion: The AAO model may provide reliable predictions by employing the effect of XDP genetic modifiers of AAO variability.

Keywords: X‐linked dystonia‐parkinsonism (XDP); age at onset; genetic modifiers; hexanucleotide repeat numbers.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Genetic analyses in patients from Koronadal. (A) Inverse correlation between AAO (age at onset) and repeat number in the cohort of 27 genetically confirmed XDP (X‐linked dystonia parkinsonism) patients (blue regression line) corresponds to the previously reported findings (red regression line). (B) Correlation between the difference in estimated AAO and actual AAO and repeat number.

References

    1. Lee LV, Rivera C, Teleg RA, et al. The unique phenomenology of sex‐linked dystonia parkinsonism (XDP, DYT3, "Lubag"). Int J Neurosci 2011;121(Suppl 1):3–11. 10.3109/00207454.2010.526728. - DOI - PubMed
    1. Westenberger A, Reyes CJ, Saranza G, et al. A hexanucleotide repeat modifies expressivity of X‐linked dystonia parkinsonism. Ann Neurol 2019;85:812–822. 10.1002/ana.25488. - DOI - PubMed
    1. Pauly MG, Ruiz López M, Westenberger A, et al. Expanding data collection for the MDSGene database: X‐linked dystonia‐parkinsonism as use case example. Mov Disord 2020;35:1933–1938. 10.1002/mds.28289. - DOI - PubMed
    1. Laabs BH, Klein C, Pozojevic J, et al. Identifying genetic modifiers of age‐associated penetrance in X‐linked dystonia‐parkinsonism. Nat Commun 2021;12:3216. 10.1038/s41467-021-23491-4. - DOI - PMC - PubMed
    1. Aneichyk T, Hendriks WT, Yadav R, et al. Dissecting the causal mechanism of X‐linked dystonia‐parkinsonism by integrating genome and transcriptome assembly. Cell 2018;172:897–909.e21. 10.1016/j.cell.2018.02.011. - DOI - PMC - PubMed

Supplementary concepts

LinkOut - more resources